Clinical Trial Update: An Open-Label Comparison of Duloxetine to Other Alternatives for the Management of Diabetic Peripheral Neuropathic Pain [Phase 4]

View source ↗

Summary

This open-label Phase 4 trial compared duloxetine to other treatment options for diabetic peripheral neuropathic pain and reported the results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetic Neuropathy, Painful | Phase 4 | Status: COMPLETED | Results posted: 2010-10-18